Literature DB >> 16703504

Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

Chung-Lam Cheung1, Jane M Rayner, Gavin J D Smith, Pui Wang, T S P Naipospos, Jinxia Zhang, Kwok-Yung Yuen, Robert G Webster, J S Malik Peiris, Yi Guan, Honglin Chen.   

Abstract

We examined the distribution of genetic mutations associated with resistance to the M2 ion channel-blocking adamantane derivatives, amantadine and rimantadine, among H5N1 viruses isolated in Vietnam, Thailand, Cambodia, Indonesia, Hong Kong, and China. More than 95% of the viruses isolated in Vietnam and Thailand contained resistance mutations, but resistant mutants were less commonly isolated in Indonesia (6.3% of isolates) and China (8.9% of isolates), where human infection was recently reported. The dual mutation motif Leu26Ile-Ser31Asn (leucine-->isoleucine at aa 26 and serine-->asparagine at aa 31) was found almost exclusively in all resistant isolates from Vietnam, Thailand, and Cambodia, suggesting the biological selection of these mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703504     DOI: 10.1086/504723

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  110 in total

1.  Mast cell-induced lung injury in mice infected with H5N1 influenza virus.

Authors:  Yanxin Hu; Yi Jin; Deping Han; Guozhong Zhang; Shanping Cao; Jingjing Xie; Jia Xue; Yi Li; Di Meng; Xiaoxu Fan; Lun-Quan Sun; Ming Wang
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

Review 2.  Novel vaccines against influenza viruses.

Authors:  S M Kang; J M Song; R W Compans
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

3.  Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.

Authors:  Yacine Abed; Andrés Pizzorno; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 4.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

5.  An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.

Authors:  Hsueh-Ling Janice Oh; Sara Akerström; Shuo Shen; Sándor Bereczky; Helen Karlberg; Jonas Klingström; Sunil K Lal; Ali Mirazimi; Yee-Joo Tan
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  Influenza Virus.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

7.  Emergence of amantadine-resistant avian influenza H5N1 virus in India.

Authors:  C Tosh; H V Murugkar; S Nagarajan; S Tripathi; M Katare; R Jain; R Khandia; Z Syed; P Behera; S Patil; D D Kulkarni; S C Dubey
Journal:  Virus Genes       Date:  2010-10-16       Impact factor: 2.332

8.  Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.

Authors:  Jae-Min Song; Jaber Hossain; Dae-Goon Yoo; Aleksandr S Lipatov; C Todd Davis; Fu-Shi Quan; Li-Mei Chen; Robert J Hogan; Ruben O Donis; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2010-06-26       Impact factor: 3.616

9.  Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.

Authors:  David A Boltz; Bounlom Douangngeun; Phouvong Phommachanh; Settha Sinthasak; Ricarda Mondry; Caroline Obert; Patrick Seiler; Rachael Keating; Yasuo Suzuki; Hiroaki Hiramatsu; Elena A Govorkova; Robert G Webster
Journal:  J Gen Virol       Date:  2009-12-16       Impact factor: 3.891

10.  Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding.

Authors:  Neal Van Hoeven; Jessica A Belser; Kristy J Szretter; Hui Zeng; Peter Staeheli; David E Swayne; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.